HD-OPM Archive
Topics › Supplements & vitamins

TARGET-D: tailored vitamin D dosing missed its main endpoint but cut heart attack 52%

Gokhan Can · Nov 10, 2025 · ♥ 25 reactions · 11 comments · original Facebook post
Supplements & vitaminsHeart attack, stroke & procedures
AI summary & key facts

Summarises TARGET-D (630 adults with acute coronary syndrome, ~4.2 years): doses adjusted to reach 40-80 ng/mL did not significantly reduce the composite of death, heart failure hospitalization or stroke, though heart attack risk was 52% lower. Authors call for validation to rule out data mining.

The TARGET-D randomized clinical trial followed 630 adults (average age 63, 78% male) with acute coronary syndrome for an average of 4.2 years. Over 85% of participants began the study with vitamin D levels below 40 ng/mL. Participants were randomized into either a standard care group or a treatment group that received personalized vitamin D doses, which were adjusted every three months to achieve a target blood level of 40-80 ng/mL; notably, nearly 52% of this group required over 5,000 IU daily to reach this target. While this tailored approach did not significantly reduce the primary composite outcome of death, heart failure hospitalization, or stroke (MACE), it was associated with a 52% lower risk of heart attack. These preliminary findings require validation in a follow up cohort to eliminate the risk of data mining.

American Heart AssociationHeart attack risk halved in adults with heart disease taking tailored vitamin D dosesResearch Highlights: Adults with heart disease prescribed vitamin D in doses tailored to reach blood levels considered optimal for heart health (>40-80 ng/mL) had a reduced risk of heart attack by more than half (52%) compared to those who did not...newsroom.heart.org

Research cited

#vitamind#vitamins#heartattack#heartfailure#stroke
← newer: Small Swedish study: colesevelam lowered blood PFAS up to 38older: Cardiovascular disease is multifactorial: inflammation, infe →